Evaluation of loop mediated isothermal amplification (LAMP) assay in the diagnosis of tubercular lymphadenitis: A pilot study [0.03%]
结核性淋巴结炎诊断中等温扩增（LAMP）检测评估：一项初步研究
Baijayantimala Mishra,Vinaykumar Hallur,Bijayini Behera et al.
Baijayantimala Mishra et al.
Tubercular lymphadenitis (TBLA) contributes to 30-40% of extrapulmonary TB cases in the immunocompetent individuals and 40-50% in people with HIV. Current diagnostic methods for TBLA like Gene-Xpert or PCR are costly and conventional method...
Efficacy of alternate day Directly Observed Treatment Short-course (DOTS) in skeletal tuberculosis - A retrospective study [0.03%]
隔日督导短程化疗治疗骨关节结核的疗效回顾性研究
Rajat Chopra,Rama Bhatt,S K Biswas et al.
Rajat Chopra et al.
Objective: To assess the efficacy of alternate day (thrice a week) Directly Observed Treatment Short-course (DOTS) regimen spanning six to nine months in providing sustained cure for skeletal tuberculosis (TB) under progr...
Initial airflow obstruction in new cases of pulmonary tuberculosis: Complication, comorbidity or missed? [0.03%]
新发肺结核病例初始出现的气流受限是并发症、合并症还是漏诊？
Andrii Dudnyk,Svitlana Blyzniuk,Oleksandr Pavel&#x;chuk et al.
Andrii Dudnyk et al.
Tuberculosis (TB) may have a similar spirometry findings as a chronic obstructive pulmonary disease but the prevalence of TB-induced airflow obstruction (AO) is still unknown. ...
Surinder K Jindal
Surinder K Jindal
Amplification of Hsp 65 gene and usage of restriction endonuclease for identification of non tuberculous rapid grower mycobacterium [0.03%]
热休克蛋白65基因扩增及内切酶识别位点分析在非结核分枝杆菌快长菌鉴定中的应用研究
Ajoy Kumar Verma,Rohit Sarin,Vijay Kumar Arora et al.
Ajoy Kumar Verma et al.
Background: The rapid grower mycobacteria have emerged as significant group of human pathogen amongst the Runyon group IV organisms that are capable of causing infection in both the healthy and immunocompromised hosts. St...
Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India [0.03%]
印度结核性脑膜炎患者中分离出的异烟肼和利福平低度耐药的结核分枝杆菌
Renu Gupta,Rajeev Thakur,Suman Kushwaha et al.
Renu Gupta et al.
Background: Heteroresistant Mycobacterium tuberculosis (mixture of susceptible and resistant subpopulations) is thought to be a preliminary stage to full resistance and timely detection, initiation of correct treatment is...
Multicenter Study
The Indian journal of tuberculosis. 2018 Jan;65(1):52-56. DOI:10.1016/j.ijtb.2017.08.005 2018
Prevalence of chronic respiratory diseases from a rural area in Kerala, southern India [0.03%]
印度南部喀拉拉邦农村地区慢性呼吸系统疾病的患病率
Krishnaveni Viswanathan,P S Rakesh,Shibu Balakrishnan et al.
Krishnaveni Viswanathan et al.
Background: Chronic lung diseases are one of the leading causes of morbidity in developing countries. A community based survey was undertaken with an objective to estimate the prevalence of chronic respiratory diseases an...
Multicenter Study
The Indian journal of tuberculosis. 2018 Jan;65(1):48-51. DOI:10.1016/j.ijtb.2017.01.010 2018
Social support a key factor for adherence to multidrug-resistant tuberculosis treatment [0.03%]
社会支持是耐多药结核病治疗依从性的关键因素
R D Deshmukh,D J Dhande,K S Sachdeva et al.
R D Deshmukh et al.
Background: Multidrug-resistant tuberculosis (MDR-TB) is emerging as a major public health problem globally. Treatment success rates in MDR-TB across the globe are not encouraging as completing MDR-TB treatment successful...
Devesh Gupta
Devesh Gupta
India's National Strategic Plan (NSP) for TB Elimination 2017-25 looks ambitious in terms of targets of TB notification aiming to reach 35 lakh TB patients annually, i.e. double that of current status. Strategies and interventions designed ...
Plasma levels of Rifampicin and Pyrazinamide with pre and post meal administration in tuberculosis patients [0.03%]
空腹和饭后给药对结核病患者利福平和吡嗪酰胺血浆浓度的影响
Parveen Kumar Sharma,Rekha Bansal,Ashok Kumar Bhardwaj et al.
Parveen Kumar Sharma et al.
Context: Various factors affect plasma concentrations of antitubercular drugs in different populations so dosing schedule should be adjusted after therapeutic drug monitoring. ...
Randomized Controlled Trial
The Indian journal of tuberculosis. 2018 Jan;65(1):35-40. DOI:10.1016/j.ijtb.2017.08.004 2018